A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days

Nature Medicine

Volumn 19, Issue 11, 2013, Pages 1542-1546

  Kobayashi, Eiji ^a   Mizukoshi, Eishiro ^b   Kishi, Hiroyuki ^a   Ozawa, Tatsuhiko ^a   Hamana, Hiroshi ^a   Nagai, Terumi ^a   Nakagawa, Hidetoshi ^b   Jin, Aishun ^a,c   Kaneko, Shuichi ^b   Muraguchi, Atsushi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PEPTIDE VACCINE; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN;

ANTIGEN SPECIFICITY; ANTIGENICITY; ARTICLE; CANCER PATIENT; CELL ACTIVITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DONOR; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION SYSTEM; GENE THERAPY; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE;

ALPHA-FETOPROTEINS; ANTIGENS, NEOPLASM; CANCER VACCINES; CARCINOMA, HEPATOCELLULAR; CLONING, MOLECULAR; GENE EXPRESSION; GENES, T-CELL RECEPTOR; GENES, T-CELL RECEPTOR ALPHA; GENES, T-CELL RECEPTOR BETA; GENETIC THERAPY; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOTHERAPY; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN HERPESVIRUS 4;

EID: 84887445200     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3358     Document Type: Article

References (26)

1. Morgan, R.A. et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314, 126-129 (2006).
2. Johnson, L.A. et al. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood 114, 535-546 (2009).
3. Linnemann, C., Schumacher, T.N. & Bendle, G.M. T-cell receptor gene therapy: critical parameters for clinical success. J. Invest. Dermatol. 131, 1806-1816 (2011).
4. Uttenthal, B.J., Chua, I., Morris, E.C. & Stauss, H.J. Challenges in T cell receptor gene therapy. J. Gene Med. 14, 386-399 (2012).
5. Ozawa, T., Tajiri, K., Kishi, H. & Muraguchi, A. Comprehensive analysis of the functional TCR repertoire at the single-cell level. Biochem. Biophys. Res. Commun. 367, 820-825 (2008).
6. Dash, P. et al. Paired analysis of TCR? and TCR? chains at the single-cell level in mice. J. Clin. Invest. 121, 288-295 (2011).
7. Kuzushima, K. et al. Tetramer-assisted identification and characterization of epitopes recognized by HLA A 2402-restricted Epstein-Barr virus-specific CD8+ T cells. Blood 101, 1460-1468 (2003).
8. Miyahara, Y. et al. Determination of cellularly processed HLA-A2402-restricted novel CTL epitopes derived from two cancer germ line genes, MAGE-A4 and SAGE. Clin. Cancer Res. 11, 5581-5589 (2005).
9. Okamoto, S. et al. Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR. Cancer Res. 69, 9003-9011 (2009).
10. Zhou, J., Dudley, M.E., Rosenberg, S.A. & Robbins, P.F. Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanoma. J. Immunol. 173, 7622-7629 (2004).
11. Mizukoshi, E., Nakamoto, Y., Tsuji, H., Yamashita, T. & Kaneko, S. Identification of ?-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma. Int. J. Cancer 118, 1194-1204 (2006).
12. Lim, A. et al. Frequent contribution of T cell clonotypes with public TCR features to the chronic response against a dominant EBV-derived epitope: application to direct detection of their molecular imprint on the human peripheral T cell repertoire. J. Immunol. 165, 2001-2011 (2000).
13. Argaet, V.P. et al. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J. Exp. Med. 180, 2335-2340 (1994).
14. Parkhurst, M.R. et al. T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol. Ther. 19, 620-626 (2011).
15. Butterfield, L.H. et al. A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four ?-fetoprotein peptides. Clin. Cancer Res. 12, 2817-2825 (2006).
16. Mizukoshi, E. et al. Comparative analysis of various tumor-associated antigen-specific T-cell responses in patients with hepatocellular carcinoma. Hepatology 53, 1206-1216 (2011).
17. Ueno, T., Tomiyama, H., Fujiwara, M., Oka, S. & Takiguchi, M. Functionally impaired HIV-specific CD8 T cells show high affinity TCR-ligand interactions. J. Immunol. 173, 5451-5457 (2004).
18. Morita, S., Kojima, T. & Kitamura, T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7, 1063-1066 (2000).
19. Kinsella, T.M. & Nolan, G.P. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7, 1405-1413 (1996).
20. Mizukoshi, E. et al. Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma. Hepatology 43, 1284-1294 (2006).
21. Giudicelli, V., Chaume, D. & Lefranc, M.P. IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res. 32, W435-W440 (2004).
22. Onishi, M. et al. Applications of retrovirus-mediated expression cloning. Exp. Hematol. 24, 324-329 (1996).
23. Ryan, M.D., King, A.M. & Thomas, G.P. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J. Gen. Virol. 72, 2727-2732 (1991).
24. Leisegang, M. et al. Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette. J. Mol. Med. (Berl) 86, 573-583 (2008).
25. Goldstein, A. Biostatistics: An Introductory Text (Macmillan, New York, 1964).
26. Jin, A. et al. A rapid and efficient single-cell manipulation method for screening antigen-specific antibody-secreting cells from human peripheral blood. Nat. Med. 15, 1088-1092 (2009)